Results 41 to 50 of about 20,723,496 (219)

Flash glucose monitoring in gestational diabetes mellitus: possibilities for assessing glycemic variability

Медицинский совет, 2021
Introduction. Blood glucose monitoring is critical in maintaining glycemic control in women with GDM and in reducing adverse maternal and fetal outcomes.
F. O. Ushanova, T. Yu. Demidova, M. Ya. Izmaylova   +2 more
doaj   +1 more source

Comparison of glucose monitoring between Freestyle Libre Pro and iPro2 in patients with diabetes mellitus

Journal of Diabetes Investigation, 2019
Aims/Introduction Flash and continuous glucose monitoring systems are becoming prevalent in clinical practice. We directly compared a flash glucose monitoring system (FreeStyle Libre Pro [FSL‐Pro]) with a continuous glucose monitoring system (iPro2) in ...
Ryo Kumagai, Aiko Muramatsu, Masanao Fujii, Yukino Katakura, Kei Ito, Keiko Fujie, Yoshio Nakata, Koichi Hashimoto, Hiroaki Yagyu   +8 more
doaj   +1 more source

Clinical Use of a 180-Day Implantable Glucose Monitoring System in Dogs with Diabetes Mellitus: A Case Series

Animals, 2022
The novel Eversense XL continuous glucose monitoring system (Senseonics, Inc., Germantown, Maryland) has recently been developed for monitoring diabetes in humans. The sensor is fully implanted and has a functional life of up to 180 days.
Antonio Maria Tardo, Concetta Irace, Francesca Del Baldo, Armando Foglia, Federico Fracassi   +4 more
doaj   +1 more source

Sensor-Based Technology: Bringing Value to People with Diabetes and the Healthcare System in an Evolving World

ClinicoEconomics and Outcomes Research, 2022
Judith L Glennie,1 Lori Berard,2 Fleur Levrat-Guillen3 1J.L. Glennie Consulting Inc., Aurora, Ontario, Canada; 2Nurse Consultant, Pink Pearls Inc, Winnipeg, Manitoba, Canada; 3Abbott Diabetes Care, Maidenhead, UKCorrespondence: Fleur Levrat-Guillen ...
Glennie JL, Berard L, Levrat-Guillen F
doaj  

Use of FreeStyle Libre Flash Monitor Register in the Netherlands (FLARE-NL1): Patient Experiences, Satisfaction, and Cost Analysis

International Journal of Endocrinology, 2019
In patients with diabetes mellitus (DM), adequate glucose control is of major importance. When treatment schemes become more complicated, proper self-management through intermittent self-measurement of blood glucose (SMBG), among others, becomes crucial ...
M. J. Fokkert, A. Damman, P. R. van Dijk, M. A. Edens, S. Abbes, J. Braakman, R. J. Slingerland, L. D. Dikkeschei, J. Dille, H. J. G. Bilo   +9 more
doaj   +1 more source

Modern methods for assessing compensation of diabetes mellitus. Effect of continuous glucose monitoring on glycemic control in patients with type 2 diabetes

Mìžnarodnij Endokrinologìčnij Žurnal, 2023
Background. An integral part of diabetes mellitus (DM) management is its timely diagnosis. The reference method to study the quality of glycemic control is evaluating the level of glycated hemoglobin (HbA1c) as one of the most accessible and informative ...
N.V. Pasyechko, L.V. Naumova, T.I. Krytskyy, I.P. Savchenko   +3 more
doaj   +1 more source

Application of flash glucose monitoring system in postoperative blood glucose management of kidney transplant recipients

Huli yanjiu, 2021
ObjectiveTo investigate the application effect of flash glucose monitoring （FGM） in blood glucose management of kidney transplant recipients （KTRs） with post⁃transplantation diabetes mellitus （PTDM）.MethodsA total of 36 PTDM cases of KTRs were ...
LU Xingxing, LIU Jing
doaj  

Flash glucose monitoring versus oral glucose tolerance test: mind the gap

, 2022
Wearable devices for continuous glucose monitoring (CGM) and flash glucose monitoring (FGM), also known as intermittent scanning continuous glucose monitoring (isCGM), have become largely available in high-income countries.
Valenzano Marina, Cibrario Bertolotti Ivan   +1 more
core   +1 more source

Partial depletion of plasminogen activator inhibitor‐1 decreases subcutaneous fat cell hypertrophy and liver cholesterol in high‐fat‐fed female mice

FEBS Letters, EarlyView.
Obesity raises blood levels of PAI‐1, a protein linked to metabolic dysfunction‐associated steatotic liver disease in people with obesity. In female mice fed a high‐fat diet, partially lowering PAI‐1 led to smaller subcutaneous fat cells and lower liver cholesterol, without changing body weight or insulin sensitivity.
Claudia E. Ramirez Bustamante, Robert Sharp, Pradip K. Saha, Elizabeth S. Anaya, Elizabeth L. Lieu, Evelyn L. de Groot, Pooja Patel, Mi Jeong Heo, Aaron R. Cox, Kang Ho Kim, Sean M. Hartig   +10 more
wiley   +1 more source

An Integrated Oxygen‐Supplying Device and Predictive Multiphysics Model for Extended Ambient Transport of Insulin‐Producing Cells

Advanced Functional Materials, EarlyView.
Cell therapies typically rely on cold‐chain logistics and cryopreservation, limiting access and compromising cell quality. Here, a dual‐chamber device separates an oxygen‐supplying chamber from a hyaluronic acid cargo chamber, sustaining oxygen delivery for over 70 h and enabling ambient‐temperature shipment.
Daniel A. Domingo‐Lopez, Ruth Tarpey, Benjamin Brennan, Bryan D. Boyle, Amir M. Alsharabasy, Abhik Mallick, Gabriella Bellavia, Abhay Pandit, Garry P. Duffy, Ruth E. Levey   +9 more
wiley   +1 more source